Adjuvant corneal crosslinking to prevent hyperopic LASIK regression

Ioannis M Aslanides, Achyut N MukherjeeEmmetropia Mediterranean Eye Clinic, Heraklion, Crete, GreecePurpose: To report the long term outcomes, safety, stability, and efficacy in a pilot series of simultaneous hyperopic laser assisted in situ keratomileusis (LASIK) and corneal crosslinking (CXL).Meth...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aslanides IM, Mukherjee AN
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/0c13e13e9bb94c5e9524bd3decab2de1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0c13e13e9bb94c5e9524bd3decab2de1
record_format dspace
spelling oai:doaj.org-article:0c13e13e9bb94c5e9524bd3decab2de12021-12-02T00:42:10ZAdjuvant corneal crosslinking to prevent hyperopic LASIK regression1177-54671177-5483https://doaj.org/article/0c13e13e9bb94c5e9524bd3decab2de12013-03-01T00:00:00Zhttp://www.dovepress.com/adjuvant-corneal-crosslinking-to-prevent-hyperopic-lasik-regression-a12621https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Ioannis M Aslanides, Achyut N MukherjeeEmmetropia Mediterranean Eye Clinic, Heraklion, Crete, GreecePurpose: To report the long term outcomes, safety, stability, and efficacy in a pilot series of simultaneous hyperopic laser assisted in situ keratomileusis (LASIK) and corneal crosslinking (CXL).Method: A small cohort series of five eyes, with clinically suboptimal topography and/or thickness, underwent LASIK surgery with immediate riboflavin application under the flap, followed by UV light irradiation. Postoperative assessment was performed at 1, 3, 6, and 12 months, with late follow up at 4 years, and results were compared with a matched cohort that received LASIK only.Results: The average age of the LASIK-CXL group was 39 years (26–46), and the average spherical equivalent hyperopic refractive error was +3.45 diopters (standard deviation 0.76; range 2.5 to 4.5). All eyes maintained refractive stability over the 4 years. There were no complications related to CXL, and topographic and clinical outcomes were as expected for standard LASIK.Conclusion: This limited series suggests that simultaneous LASIK and CXL for hyperopia is safe. Outcomes of the small cohort suggest that this technique may be promising for ameliorating hyperopic regression, presumed to be biomechanical in origin, and may also address ectasia risk.Keyword: CXLAslanides IMMukherjee ANDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2013, Iss default, Pp 637-641 (2013)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Aslanides IM
Mukherjee AN
Adjuvant corneal crosslinking to prevent hyperopic LASIK regression
description Ioannis M Aslanides, Achyut N MukherjeeEmmetropia Mediterranean Eye Clinic, Heraklion, Crete, GreecePurpose: To report the long term outcomes, safety, stability, and efficacy in a pilot series of simultaneous hyperopic laser assisted in situ keratomileusis (LASIK) and corneal crosslinking (CXL).Method: A small cohort series of five eyes, with clinically suboptimal topography and/or thickness, underwent LASIK surgery with immediate riboflavin application under the flap, followed by UV light irradiation. Postoperative assessment was performed at 1, 3, 6, and 12 months, with late follow up at 4 years, and results were compared with a matched cohort that received LASIK only.Results: The average age of the LASIK-CXL group was 39 years (26–46), and the average spherical equivalent hyperopic refractive error was +3.45 diopters (standard deviation 0.76; range 2.5 to 4.5). All eyes maintained refractive stability over the 4 years. There were no complications related to CXL, and topographic and clinical outcomes were as expected for standard LASIK.Conclusion: This limited series suggests that simultaneous LASIK and CXL for hyperopia is safe. Outcomes of the small cohort suggest that this technique may be promising for ameliorating hyperopic regression, presumed to be biomechanical in origin, and may also address ectasia risk.Keyword: CXL
format article
author Aslanides IM
Mukherjee AN
author_facet Aslanides IM
Mukherjee AN
author_sort Aslanides IM
title Adjuvant corneal crosslinking to prevent hyperopic LASIK regression
title_short Adjuvant corneal crosslinking to prevent hyperopic LASIK regression
title_full Adjuvant corneal crosslinking to prevent hyperopic LASIK regression
title_fullStr Adjuvant corneal crosslinking to prevent hyperopic LASIK regression
title_full_unstemmed Adjuvant corneal crosslinking to prevent hyperopic LASIK regression
title_sort adjuvant corneal crosslinking to prevent hyperopic lasik regression
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/0c13e13e9bb94c5e9524bd3decab2de1
work_keys_str_mv AT aslanidesim adjuvantcornealcrosslinkingtopreventhyperopiclasikregression
AT mukherjeean adjuvantcornealcrosslinkingtopreventhyperopiclasikregression
_version_ 1718403477443444736